These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31321000)

  • 1. Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis
    Maiuri L; Raia V; Piacentini M; Tosco A; Villella VR; Kroemer G
    Oncotarget; 2019 Jul; 10(43):4492-4500. PubMed ID: 31321000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective proteostasis in celiac disease as a new therapeutic target.
    Maiuri L; Villella VR; Piacentini M; Raia V; Kroemer G
    Cell Death Dis; 2019 Feb; 10(2):114. PubMed ID: 30737369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis.
    Villella VR; Esposito S; Ferrari E; Monzani R; Tosco A; Rossin F; Castaldo A; Silano M; Marseglia GL; Romani L; Barlev NA; Piacentini M; Raia V; Kroemer G; Maiuri L
    Cell Death Dis; 2019 Mar; 10(4):258. PubMed ID: 30874543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gliadin-CFTR connection: new perspectives for the treatment of celiac disease.
    Maiuri L; Villella VR; Raia V; Kroemer G
    Ital J Pediatr; 2019 Mar; 45(1):40. PubMed ID: 30898172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease.
    Esposito S; Villella VR; Ferrari E; Monzani R; Tosco A; Rossin F; D'Eletto M; Castaldo A; Luciani A; Silano M; Bona G; Marseglia GL; Romani L; Piacentini M; Raia V; Kroemer G; Maiuri L
    Aging (Albany NY); 2019 Apr; 11(7):2003-2019. PubMed ID: 30981209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease.
    Villella VR; Venerando A; Cozza G; Esposito S; Ferrari E; Monzani R; Spinella MC; Oikonomou V; Renga G; Tosco A; Rossin F; Guido S; Silano M; Garaci E; Chao YK; Grimm C; Luciani A; Romani L; Piacentini M; Raia V; Kroemer G; Maiuri L
    EMBO J; 2019 Jan; 38(2):. PubMed ID: 30498130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis.
    Esposito S; Tosco A; Villella VR; Raia V; Kroemer G; Maiuri L
    Mol Cell Pediatr; 2016 Dec; 3(1):13. PubMed ID: 26976279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel.
    Wu YS; Jiang J; Ahmadi S; Lew A; Laselva O; Xia S; Bartlett C; Ip W; Wellhauser L; Ouyang H; Gonska T; Moraes TJ; Bear CE
    Mol Pharmacol; 2019 Oct; 96(4):515-525. PubMed ID: 31427400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.
    Pettit RS
    Ann Pharmacother; 2012; 46(7-8):1065-75. PubMed ID: 22739718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
    Kuk K; Taylor-Cousar JL
    Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
    Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
    J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect.
    Villella VR; Esposito S; Bruscia EM; Maiuri MC; Raia V; Kroemer G; Maiuri L
    Front Pharmacol; 2013; 4():1. PubMed ID: 23346057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy delays progression of the two most frequent human monogenetic lethal diseases: cystic fibrosis and Wilson disease.
    Maiuri L; Kroemer G
    Aging (Albany NY); 2018 Dec; 10(12):3657-3661. PubMed ID: 30568028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of
    Ghelani DP; Schneider-Futschik EK
    ACS Pharmacol Transl Sci; 2020 Feb; 3(1):4-10. PubMed ID: 32259083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
    Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.
    Raju SV; Lin VY; Liu L; McNicholas CM; Karki S; Sloane PA; Tang L; Jackson PL; Wang W; Wilson L; Macon KJ; Mazur M; Kappes JC; DeLucas LJ; Barnes S; Kirk K; Tearney GJ; Rowe SM
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):99-108. PubMed ID: 27585394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.
    Tazi MF; Dakhlallah DA; Caution K; Gerber MM; Chang SW; Khalil H; Kopp BT; Ahmed AE; Krause K; Davis I; Marsh C; Lovett-Racke AE; Schlesinger LS; Cormet-Boyaka E; Amer AO
    Autophagy; 2016 Nov; 12(11):2026-2037. PubMed ID: 27541364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.
    Yu YC; Sohma Y; Hwang TC
    J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis: a disorder with defective autophagy.
    Luciani A; Villella VR; Esposito S; Brunetti-Pierri N; Medina DL; Settembre C; Gavina M; Raia V; Ballabio A; Maiuri L
    Autophagy; 2011 Jan; 7(1):104-6. PubMed ID: 21048426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adapting Proteostasis and Autophagy for Controlling the Pathogenesis of Cystic Fibrosis Lung Disease.
    Bodas M; Vij N
    Front Pharmacol; 2019; 10():20. PubMed ID: 30774592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.